News tagged with malignancy
Heart disease may be a risk factor for prostate cancer
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions ...
Feb 08, 2012 |
5 / 5 (1) |
0
|
Drugs targeting chromosomal instability may fight a particular breast cancer subtype
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
A thought-provoking new therapeutic target for brain cancer?
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Feb 01, 2012 |
not rated yet |
0
Project to improve radiotherapy planning
A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. ...
Jan 30, 2012 |
not rated yet |
0
Standard treatments for head and neck cancer less effective in HIV-positive patients
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary ...
Jan 26, 2012 |
5 / 5 (1) |
0
New therapeutic target to combat liver cancer discovered
Spanish researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the ...
Jan 26, 2012 |
not rated yet |
0
Molecular fingerprint discovered that may improve outcomes for head and neck cancer patients
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's ...
Jan 23, 2012 |
not rated yet |
0
|
Software for analyzing digital pathology images proving its usefulness
As tissue slides are more routinely digitized to aid interpretation, a software program whose design was led by the University of Michigan Health System is proving its utility.
Jan 13, 2012 |
5 / 5 (1) |
0
|
Exercise in a pill may protect against extreme heat sensitivity
We've all seen the story in the news before. Whether it's the death of a physically fit high school athlete at football training camp in August, or of an elderly woman gardening in the middle of the day in July, heat stroke ...
Jan 08, 2012 |
4.8 / 5 (5) |
0
|
Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt ...
Jan 06, 2012 |
not rated yet |
0
Cell-CT: A new dimension in breast cancer research
Despite advances in both the diagnosis and treatment of breast cancer, the disease remains a leading worldwide health concern.
Jan 05, 2012 |
5 / 5 (2) |
0
|
Anti-sense might make sense for treating liver cancer
A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The findings might offer a new therapy for this malignancy, which kills an estimated 549,000 people ...
Jan 03, 2012 |
not rated yet |
0
Discovery of new vaccine approach for treatment of cancer
(Medical Xpress) -- Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental ...
Dec 21, 2011 |
5 / 5 (3) |
0
Removal of lymph nodes during surgery for thyroid cancer may be beneficial
Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent ...
Dec 20, 2011 |
not rated yet |
0
|
Novel immuno-gene therapy shows promise for the treatment of rare, deadly form of cancer
(Medical Xpress) -- Researchers at the Perelman School of Medicine at the University of Pennsylvania report promising new results from a small clinical trial using an immune-system-based gene therapy for treating advanced ...
Dec 16, 2011 |
5 / 5 (1) |
0
|
Malignancy
Malignancy (from the Latin roots mal- = "bad" and -genus = "born") is the tendency of a medical condition, especially tumors to become progressively worse and to potentially result in death. It is characterized by the properties of anaplasia, invasiveness, and metastasis. Malignant is a corresponding adjectival medical term used to describe a severe and progressively worsening disease. The term is most familiar as a description of cancer. A malignant tumor may be contrasted with a non-cancerous benign tumor in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues (metastasizing), while a benign tumor has none of those properties. Malignant tumor is synonymous with cancer. Uses of "malignant" in oncology:
Non-oncologic disorders referred to as "malignant":
For more information about Malignancy, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
